Get started
Author

Mark Laible

Genome-wide DNA Methylation Events in TMPRSS2–ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
2012 · Stefan T. Börno, Axel Fischer, et al. · Cancer Discovery · 137
Homemade Site Directed Mutagenesis of Whole Plasmids
2009 · Mark Laible, Kajohn Boonrod · Journal of Visualized Experiments · 98
PDF
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
2017 · Hans-Peter Sinn, Andreas Schneeweiss, et al. · BMC Cancer · 94
PDF
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
2016 · Mark Laible, Kornelia Schlombs, et al. · BMC Cancer · 54
PDF
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®
2017 · Zsuzsanna Varga, Annette Lebeau, et al. · Breast Cancer Research · 39
PDF
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
2016 · Ralph M. Wirtz, Harri Sihto, et al. · Breast Cancer Research and Treatment · 39
PDF
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
2016 · Johannes Breyer, Wolfgang Otto, et al. · Urologia Internationalis · 37
PDF
Homemade Site Directed Mutagenesis of Whole Plasmids
2009 · Mark Laible, Kajohn Boonrod · Journal of Visualized Experiments · 37
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis
2023 · Adrian Georg Simon, Su Ir Lyu, et al. · Journal of Translational Medicine · 30
PDF
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
2017 · Leonie Ratz, Mark Laible, et al. · Oncotarget · 30
PDF
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)
2016 · Johannes Breyer, Ralph M. Wirtz, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 29
ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer
2013 · Lukasz A. Kacprzyk, Mark Laible, et al. · PLoS ONE · 27
PDF
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
2017 · Johannes Breyer, Ralph Markus Wirtz, et al. · Oncotarget · 20
PDF
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
2019 · Mark Laible, Kerstin Hartmann, et al. · BMC Cancer · 18
PDF
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study
2024 · Stephan Forchhammer, Oltin Tiberiu Pop, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 16
Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR
2021 · Emanuele Caselli, Cristina Pelliccia, et al. · PLoS ONE · 15
PDF
Contact spotting of protein microarrays coupled with spike‐in of normalizer protein permits time‐resolved analysis of ERBB receptor signaling
2008 · Christian Löbke, Mark Laible, et al. · PROTEOMICS · 14
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors
2025 · Peter J Madsen, Anna Melissa Schlitter, et al. · Journal for ImmunoTherapy of Cancer · 10
PDF
The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities
2025 · Larissa Seidmann, Arthur Wingerter, et al. · Cancers · 10
PDF
Transferring a Quantitative Molecular Diagnostic Test to Multiple Real-Time Quantitative PCR Platforms
2018 · Claudia Gürtler, Mark Laible, et al. · Journal of Molecular Diagnostics · 9
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study
2024 · Francesco Schettini, Silvana Saracchini, et al. · The Breast · 7
PDF
Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue
2018 · Kerstin Hartmann, Kornelia Schlombs, et al. · Diagnostic Pathology · 6
PDF
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies
2026 · Ciara Conduit, Bruno Valentin Sinn, et al. · Therapeutic Advances in Medical Oncology · 2
Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score
2020 · Silvana Saracchini, Anna Bassini, et al. · Cancer Research · 2
Abstract P4-02-12: Comparison of RT-qPCR with consensus immunohistochemistry by three pathologists for ER, PR, HER2 and Ki-67 in Chinese breast cancer patients
2019 · X Teng, X Li, et al. · Cancer Research · 1
Works count: 64
Citation count: 785
H-index: 15
I10-index: 19
Year
Topic
Type